Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disorders

Detalhes bibliográficos
Autor(a) principal: Batista, Patrícia
Data de Publicação: 2024
Outros Autores: Cunha, Sara A., Ribeiro, Tânia, Borges, Sandra, Baptista-Silva, Sara, Oliveira-Silva, Patrícia, Pintado, Manuela
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.14/43453
Resumo: Background: Marine-derived natural products have been attracting attention from both the food and pharmaceutical sectors due to their promising therapeutic attributes. Algae and their biomolecules are examples of marine-derived products for ongoing research endeavors. Fucoidan, an algae-derived polysaccharide, has emerged as a recent biomolecule related to a diverse array of beneficial properties, with particular emphasis on its neuroprotective activities. Scope and approach: This review intended to understand the neuroprotective properties of Fucoidan and its impact on brain disorders. Fucoidan has risen to prominence as one of the most promising neuroprotective agents obtained from macroalgae, with in vitro and in vivo studies proving its efficiency. Nevertheless, the extant literature underscores the imperative for further clinical trials to substantiate its therapeutic prowess. The neuroprotective effect of fucoidan is related to oxidative stress, mitochondrial function, neuroinflammation, apoptosis, as well as the interaction between gut-brain-microbiota. Key findings and conclusions: Despite having numerous health benefits being approved by regulatory entities, fucoidan products consumption, and use by industry still needs to be explored. Henceforth, there is a need to search for an efficient method for the successful commercialization of fucoidan, focusing on its suitable dosage for pharmaceutical and nutraceutical applications, but it is also necessary to have clinical studies proving its efficacy in brain disorders. Therefore, this biomolecule has the potential to be exploited by researchers, investors and consumers. In this way, fucoidan could contribute to the promotion and improvement of society’s quality of life concerning specific brain pathologies.
id RCAP_8254030a579095205a1cb5d871a5d121
oai_identifier_str oai:repositorio.ucp.pt:10400.14/43453
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disordersMacroalgaeBioactive compoundsNew moleculesSustainabilityBrain benefitsBackground: Marine-derived natural products have been attracting attention from both the food and pharmaceutical sectors due to their promising therapeutic attributes. Algae and their biomolecules are examples of marine-derived products for ongoing research endeavors. Fucoidan, an algae-derived polysaccharide, has emerged as a recent biomolecule related to a diverse array of beneficial properties, with particular emphasis on its neuroprotective activities. Scope and approach: This review intended to understand the neuroprotective properties of Fucoidan and its impact on brain disorders. Fucoidan has risen to prominence as one of the most promising neuroprotective agents obtained from macroalgae, with in vitro and in vivo studies proving its efficiency. Nevertheless, the extant literature underscores the imperative for further clinical trials to substantiate its therapeutic prowess. The neuroprotective effect of fucoidan is related to oxidative stress, mitochondrial function, neuroinflammation, apoptosis, as well as the interaction between gut-brain-microbiota. Key findings and conclusions: Despite having numerous health benefits being approved by regulatory entities, fucoidan products consumption, and use by industry still needs to be explored. Henceforth, there is a need to search for an efficient method for the successful commercialization of fucoidan, focusing on its suitable dosage for pharmaceutical and nutraceutical applications, but it is also necessary to have clinical studies proving its efficacy in brain disorders. Therefore, this biomolecule has the potential to be exploited by researchers, investors and consumers. In this way, fucoidan could contribute to the promotion and improvement of society’s quality of life concerning specific brain pathologies.Veritati - Repositório Institucional da Universidade Católica PortuguesaBatista, PatríciaCunha, Sara A.Ribeiro, TâniaBorges, SandraBaptista-Silva, SaraOliveira-Silva, PatríciaPintado, Manuela2024-01-03T12:01:19Z2024-012024-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.14/43453eng0924-224410.1016/j.tifs.2023.10430085182414865001148285200001info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-13T01:33:39Zoai:repositorio.ucp.pt:10400.14/43453Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T01:30:51.544830Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disorders
title Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disorders
spellingShingle Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disorders
Batista, Patrícia
Macroalgae
Bioactive compounds
New molecules
Sustainability
Brain benefits
title_short Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disorders
title_full Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disorders
title_fullStr Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disorders
title_full_unstemmed Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disorders
title_sort Fucoidans: exploring its neuroprotective mechanisms and therapeutic applications in brain disorders
author Batista, Patrícia
author_facet Batista, Patrícia
Cunha, Sara A.
Ribeiro, Tânia
Borges, Sandra
Baptista-Silva, Sara
Oliveira-Silva, Patrícia
Pintado, Manuela
author_role author
author2 Cunha, Sara A.
Ribeiro, Tânia
Borges, Sandra
Baptista-Silva, Sara
Oliveira-Silva, Patrícia
Pintado, Manuela
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Veritati - Repositório Institucional da Universidade Católica Portuguesa
dc.contributor.author.fl_str_mv Batista, Patrícia
Cunha, Sara A.
Ribeiro, Tânia
Borges, Sandra
Baptista-Silva, Sara
Oliveira-Silva, Patrícia
Pintado, Manuela
dc.subject.por.fl_str_mv Macroalgae
Bioactive compounds
New molecules
Sustainability
Brain benefits
topic Macroalgae
Bioactive compounds
New molecules
Sustainability
Brain benefits
description Background: Marine-derived natural products have been attracting attention from both the food and pharmaceutical sectors due to their promising therapeutic attributes. Algae and their biomolecules are examples of marine-derived products for ongoing research endeavors. Fucoidan, an algae-derived polysaccharide, has emerged as a recent biomolecule related to a diverse array of beneficial properties, with particular emphasis on its neuroprotective activities. Scope and approach: This review intended to understand the neuroprotective properties of Fucoidan and its impact on brain disorders. Fucoidan has risen to prominence as one of the most promising neuroprotective agents obtained from macroalgae, with in vitro and in vivo studies proving its efficiency. Nevertheless, the extant literature underscores the imperative for further clinical trials to substantiate its therapeutic prowess. The neuroprotective effect of fucoidan is related to oxidative stress, mitochondrial function, neuroinflammation, apoptosis, as well as the interaction between gut-brain-microbiota. Key findings and conclusions: Despite having numerous health benefits being approved by regulatory entities, fucoidan products consumption, and use by industry still needs to be explored. Henceforth, there is a need to search for an efficient method for the successful commercialization of fucoidan, focusing on its suitable dosage for pharmaceutical and nutraceutical applications, but it is also necessary to have clinical studies proving its efficacy in brain disorders. Therefore, this biomolecule has the potential to be exploited by researchers, investors and consumers. In this way, fucoidan could contribute to the promotion and improvement of society’s quality of life concerning specific brain pathologies.
publishDate 2024
dc.date.none.fl_str_mv 2024-01-03T12:01:19Z
2024-01
2024-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/43453
url http://hdl.handle.net/10400.14/43453
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0924-2244
10.1016/j.tifs.2023.104300
85182414865
001148285200001
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136790409379840